Etiopathologenesis

Loss of Dopaminergic neurons from SUBSTANTIA NIGRA (Parkinson disease).

Destruction of SN neurons due to exposure to MPTP (1 METHYL 4 PHENYL 1,2,3,6 TRIHYDRO PYRIDINE) – contaminant of illicit opioids. (Acute Parkinsonian syndrome)

Gut-Brain hypothesis (enteric NS to medulla)

Clinical features

  • Triad (all motor – due to SN involvement)
    • Tremor (pill rolling tremor)
    • Rigidity
    • Bradykinesia
  • Responds to L-Dopa.
  • Appearance:
    • Masked face – less expression
    • Stooped posture
    • Slowing of voluntary movement (Bradykinesia)
    • FESTINATING gait

Pathology

Protein accumulation in cytoplasm, mitochondrial damage, lysosomal dysfunction (a/w Gaucher disease).

Diagnostic hallmark: Alpha Synuclein: Major component of Lewy body.
Encoded by SCNA gene.
Effect like Alzheimer’s (ABeta) – forms deposits.
Propogates like Prion (PrPsc).
Other proteins: DJ1, PINK1, PARKIN. These are involved in Mitochondrial dysfunction.

Morphology

SN Pallor. (White)
Neuronal loss + reactive gliosis
Lewy bodies – eosinophilic irregular multiple cytoplasmic inclusions with halo.
Densely packed filaments of alpha synucelin.

Histological sample of Substantia nigra in Parkinson's disease

What?

Progressive loss of a group of neurons having same function.

All are Proteinopathies.
Caused due to accumulation of insoluble proteins.
Tangle / plaque / lewy body.

List:

  • Prion disease
  • Alzheimers disease
  • Fronto-temporal lobar degeneration (FTLD)
  • Parkinson disease
  • Atypical Parkinson disease
  • Huntington disease
  • Spinocerebellar generation
  • Amyotrophic lateral sclerosis (ALS)
    • LMN and UMN Palsy with Bulbar involvement. (Swallowing)
  • Other motor neuron diseases